These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 9466020

  • 41. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R, Colby C, El-Etr A, Pifarré R.
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y, Imai Y, Seo K, Terada M, Aoki M, Shin'oka T.
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [Abstract] [Full Text] [Related]

  • 46. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

  • 47. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
    Radulovic V, Laffin A, Hansson KM, Backlund E, Baghaei F, Jeppsson A.
    PLoS One; 2015 Feb; 10(7):e0130271. PubMed ID: 26134993
    [Abstract] [Full Text] [Related]

  • 48. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal?
    Gatti G, Pugliese P.
    Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433
    [Abstract] [Full Text] [Related]

  • 49. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C, Feddersen K, Rådegran K.
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
    [Abstract] [Full Text] [Related]

  • 50. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
    Arsenault KA, Paikin JS, Hirsh J, Dale B, Whitlock RP, Teoh K, Young E, Ginsberg JS, Weitz JI, Eikelboom JW.
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB.
    ASAIO J; 1997 Oct; 43(5):M825-30. PubMed ID: 9360162
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device.
    Noui N, Zogheib E, Walczak K, Werbrouck A, Amar AB, Dupont H, Caus T, Remadi JP.
    Perfusion; 2012 May; 27(3):214-20. PubMed ID: 22301392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.